Unstandardized combination

KLOW

KPV + GHK-Cu + BPC-157 + TB-500

Uncertain or Concerning

Video guide

Video guides are coming soon.

Identity

Commercial or common name

KLOW. This name is not standardized.

Variants

Reported formulation variants

No authoritative formulation specification

Combination evidence

What the combination shows

No adequate human combination evidence was identified in the static MVP review. Component-level findings do not transfer to the combination.

Regulatory

Status

Unapproved / RUO. No approval is implied by use of a commercial or community name.

Human research

Combination trial status

No validated human combination trial identified

Quality

Stability and compatibility

Compatibility, sterility and stability are not established across marketed variants

Claims

Common marketing claims

Inflammation control
Skin and gut support

Evidence-based conclusion

Bottom line

This named stack should be evaluated as an unstandardized combination. It does not inherit the evidence score of its strongest component.

Individual component evidence

Experimental / RUOVerification pending

KPV

Lys-Pro-Val

A three-amino-acid fragment studied for inflammation-related effects.

Tier 3Unapproved / RUO

Cosmetic / TopicalVerification pending

GHK-Cu

Copper peptide

A copper-binding peptide used in cosmetic products and discussed in skin-repair research.

Tier 3Cosmetic

Experimental / RUOVerification pending

BPC-157

Body protection compound 157

A research peptide often marketed for gut, tendon and injury recovery.

Tier 3Unapproved / RUO

Experimental / RUOVerification pending

TB-500

Thymosin beta-4 fragment

A commercial research label associated with thymosin beta-4-related products.

Tier 3Unapproved / RUO